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Background
Differentiated thyroid carcinoma (DTC) is the most com-
mon endocrine malignancy, and it usually has a favoura-
ble course, with a good prognosis, more than 90% at 10-
year follow-up. Nevertheless, a subset of patients develops
local recurrence or distant metastasis and may die from
DTC, indicating the possibility of more aggressive variants
of this carcinoma. In this study we retrospectively ana-
lyzed the incidence, the treatment and the stage of DTC in
a selected group of patients aged 70 or more years old
compared with a group of patients less than 70 years old.
Methods
From 1995 to 2007, 1520 patients underwent surgery for
thyroid carcinoma, at our Institute. Descriptive demo-
graphic data, surgical details and stage were recorded.
Results
1407 out of 1520 patients affected by thyroid cancer had
DTC (92.5%), 97 had medullary thyroid cancer and 16
anaplastic tumor, respectively.
Regarding age, 1290 cases (1222 papillary and 68 follicu-
lar, 91.7%), were less than 70 years old (group 1) while
117 cases (107 papillary and 10 follicular, 8.3%) were
aged 70 years or more (group 2).
In the younger group total thyroidectomy was performed
in 1090 patients (84.5%), associated with nodal dissec-
tion (central +/- lateral compartment) in 917 (84.1%),
while in the older group total thyroidectomy was done in
99 (84.6%) associated with node dissection in 65 cases
(65.6%). In 218 cases a partial thyroidectomy was per-
formed (200 in group 1, 15.5% and 18 in group 2,
15.4%). The distribution of the stage in group 1 was the
following: stage I 1098 patients (85.2%), stage II 12 (1%),
stage III 130 (10%) and stage IV 50 (3.8%) while in group
2 was: stage I 84 cases (71.8%), stage II 1 (0.9%), stage III
14 (11.9%) and stage IV 18 (15.4%). The overall 5- and
10-year survival rates were 71.8% and 63.9%, respectively,
with an overall recurrence rate of 17.9%.
Conclusion
Our data allowed us to draw these conclusions:
1. The incidence of DTC is increased in the past three dec-
ades especially for the papillary variety, that in our experi-
ence represent 88% of entire series;
2. The presence of advanced stage (III and IV) is more fre-
quent in older patients than in younger, 27.3% vs 13.8%,
respectively, especially for stage IV;
3. The incidence of aggressive anaplastic cancer in group 2
is much greater than group 1, 6% vs 0.6% respectively;
Finally, very few studies had evaluated the DTC in older
patients. All these patients should be considered high-risk
subjects to be given the best therapeutic option, that is to
say total thyroidectomy plus node dissection when neces-
sary.
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